Announcement on the Receipt of Clinical Trial Approval Notice for B023 Cell Injection Solution

About this update from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

Announcement on the Receipt of Clinical Trial Approval Notice for B023 Cell Injection Solution The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Pharmaceuticals Holding Co. Ltd. Class A